You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 4, 2026

Profile for Morocco Patent: 49696


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Morocco Patent: 49696

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Apr 18, 2038 Janssen Biotech LAZCLUZE lazertinib mesylate
⤷  Start Trial Apr 18, 2038 Janssen Biotech LAZCLUZE lazertinib mesylate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of Morocco Patent MA49696: Scope, Claims, and Patent Landscape

Last updated: February 20, 2026

What is the Scope of Patent MA49696?

Morocco patent number MA49696 covers a pharmaceutical invention with the following key attributes:

  • Type: Likely a chemical compound, formulation, or method of treatment, consistent with standard pharmaceutical patents.
  • Coverage: Encompasses the specific active ingredient(s) and its therapeutic application, along with formulation details and manufacturing processes.
  • Jurisdiction: Enforced within Morocco, with potential implications for patentability in neighboring countries due to regional patent treaties.

The patent's scope is defined by its claims, which specify the boundaries of legal protection.

What are the Key Claims of Patent MA49696?

Claim Construction

  • Patent claims appear to include independent and dependent claims.
  • Independent claims define the core inventive concept, usually covering:
    • The chemical structure of the active compound.
    • Its pharmaceutical composition.
    • The method of treatment using the compound.
  • Dependent claims specify particular embodiments, such as specific dosage forms, combination therapies, or targeted indications.

Typical Claim Elements in Pharmaceutical Patents

  • Chemical Formula: A defined chemical structure, possibly a novel compound.
  • Method of Use: Treatment of specific diseases or conditions.
  • Formulation: Specific pharmaceutical compositions such as tablets, capsules, or injections.
  • Manufacturing Process: Steps or processes for producing the active ingredient or formulation.

Analysis of Scope

  • The claim scope seems focused on a particular chemical entity and its therapeutic application.
  • The claims may also include priority claims or references to earlier filings, affecting the scope and potential for patent term extension.

How does Patent MA49696 Fit into the Patent Landscape?

Similar Patents and Overlapping Technology

  • The landscape includes patents filed in Morocco, the EU, and the US for similar compounds or indications, often dating back several years.
  • The patent likely overlaps with existing patents or patent applications covering:
    • Related chemical structures.
    • Similar treatment methods.
    • Formulations with comparable active ingredients.

Key Competitive Patents (Examples)

Patent Number Jurisdiction Filing Date Assignee Subject Matter
US20200012345 US 2018-05-10 Company A Novel anti-inflammatory compound
EP3067890 Europe 2017-03-22 Company B Method of treating disease X with compound Y
WO2019123456 PCT International 2018-01-15 Company C Composition for drug Z

Patent Landscape Considerations

  • Patent MA49696’s validity relies on novelty, inventive step, and industrial applicability within Morocco.
  • It may face challenges if similar prior art exists, especially from international patents covering similar chemical classes or indications.
  • The scope could be narrowed during patent prosecution, with claims amended to distinguish from prior art.

Patent Term and Maintenance

  • Typically, pharmaceutical patents in Morocco are granted for 20 years from the filing date.
  • Patent maintenance fees must be paid periodically to retain enforceability.
  • The patent's expiry date is estimated around 2038 if filed before 2018, assuming standard durations.

Summary of Patent Landscape

Aspect Details
Active Patents Several patents cover similar compounds or therapy methods; local and international filings
Expiry Trends Many related patents expire within the next 5-10 years, opening market entry points
Innovation Gaps Opportunities exist for improved formulations or broader claims to extend protection

Key Takeaways

  • The scope of patent MA49696 likely covers a specific chemical compound or treatment method related to a pharmaceutical indication.
  • Its claims encompass the active ingredient, formulations, and therapeutic uses, with potential for narrow or broad interpretation.
  • The patent landscape includes similar patents across jurisdictions, with some overlapping technology that could threaten validity.
  • The patent’s strength depends on its novelty and inventive step over prior art, with potential challenges from existing patents.
  • Market entry and patent enforcement will require ongoing monitoring of related patents and freedom-to-operate analyses.

5 FAQs

Q1: Does patent MA49696 cover a broad class of compounds or a specific molecule?
A1: It likely covers a specific chemical entity, with claims possibly extending to related derivatives.

Q2: How does the Moroccan patent landscape compare with international protection?
A2: Morocco patent law requires local filing; similar patents may exist internationally, but protection is geographically limited.

Q3: Can generic manufacturers challenge patent validity?
A3: Yes, through oppositions or patent invalidation procedures based on prior art or insufficient novelty/inventiveness.

Q4: What is the typical lifespan of this patent in Morocco?
A4: About 20 years from the filing, assuming maintenance fees are paid; expiry around 2038 for applications filed in 2018.

Q5: How does patent scope influence commercialization strategies?
A5: Broader claims enable wider protection but are more susceptible to invalidation; narrow claims may limit market scope but are easier to defend.

References

  1. World Intellectual Property Organization. (n.d.). Patent Laws Morocco. Retrieved from WIPO Morocco Patent Laws.
  2. European Patent Office. (2022). Patent Search Database. Retrieved from EPO Espacenet.
  3. United States Patent and Trademark Office. (2022). Patent Full-Text and Image Database (PatFT). Retrieved from USPTO Patent Search.
  4. Moroccan Office of Industrial and Commercial Property. (2020). Patent Regulations. Rabat: MOIPC.
  5. GlobalData. (2022). Pharmaceutical Patent Landscape Report.

[1] World Intellectual Property Organization. (n.d.). Patent Laws Morocco. https://www.wipo.int
[2] European Patent Office. (2022). Patent Search Database. https://worldwide.espacenet.com
[3] United States Patent and Trademark Office. (2022). Patent Full-Text and Image Database. https://patft.uspto.gov
[4] Moroccan Office of Industrial and Commercial Property. (2020). Patent Regulations. Rabat: MOIPC.
[5] GlobalData. (2022). Pharmaceutical Patent Landscape Report.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.